This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Papain, a proteolytic enzyme extracted from the latex of the papaya tree and fruit (Carica papaya), has numerous uses and applications. It is not only widely used as a meat or cephalopod tenderizer and a beer clarificant in food industry, but it is also used for pharmaceuticals and cosmetics. 1 IgE-mediated papain allergy in exposed workers was first reported in 1975. 2 The prevalence of papain sensitization among exposed individuals from a relatively small cohort study was 41%. 3 It has well documented that papain can induce reactions through different routes: respiratory, 2,4,5 skin/conjunctival, [6] [7] [8] or oral. 9 Papain allergy can occur in occupational and non-occupational settings, and most of the affected subjects work in a factory, 4 ,5 a biochemical laboratory, 2 or a beauty salon. 6, 8 Food processors may affect IgE-mediated allergic occupational diseases through halation of airborne particles, skin contact, or ingestion. Daiana et al. 10 reported occupational rhinoconjunctivitis due to maize in a snack processor. Here, we present a case of occupational, IgE-mediated papain allergy who works in a sausage processing factory.
CASE REPORT
A 53-year-old man was referred to our clinic with shortness of breath and wheezing. These symptoms improved following the use of salmeterol/flutieasone propionate on demand. The patient has a lifelong history of allergic conjunctivitis, allergic rhinitis, and childhood asthma. For 10 years, he worked in a sausage processing plant where papain was used as a meat tenderizer. The patient reported that his symptoms became more severe when he began to work at the sausage processing plant. He mentioned that some coworkers also had respiratory complaints as well. The patient experienced 2 episodes of oral itching, and angioedema of the oropharyngeal tract and tongue after eating kiwi fruit 8 years ago. He had similar symptoms within a few minutes after eating fig fruit 5 years ago. Physical examination was normal. Skin tests were positive to summer-autumn pollen I (++), spring pollen I (++), Fraxinus Americana (+) Papain is a proteolytic enzyme which is widely used in food industry, pharmaceuticals, and cosmetics. Occupational and non-occupational papain allergies have previously been documented; however, there are limited publications about papain allergy with its relative fruit allergy. Here, we present a case of occupational, IgE-mediated papain allergy with kiwi fruit and fig fruit allergy. A 53-year-old man suffered from rhinitis for several years, with the onset of his symptoms coinciding with the time he started to work at a sausage processing plant where papain is often used as a meat tenderizer. He began to experience symptoms of chest tightness, shortness of breath and wheezing shortly after starting work 5 years ago. Furthermore, he experienced several episodes of oral itching, and tongue and oropharyngeal angioedema after injestion of kiwi fruit and fig fruit. The patient had a lifelong history of allergic conjunctivitis, allergic rhinitis, and childhood asthma. Specific IgE was positive to kiwi fruit, papain and chymopapain (2.95 kUA/L, >100 kUA/L, and 95.0 kUA/L, respectively). Similar bands at 10-15 kDa in blotting with papain and kiwi fruit extracts were found. This patient showed a potential association between papain allergy and sensitization to kiwi fruit. We also reviewed 13 patients with papain allergy published in the literature, with 85% (11/13) of the patients sensitized through the respiratory tract, and 40% (4/11) having atopy. Further studies should focus on the determination of cross-reactive allergens between papain and its fruit relatives, and the prevalence of food allergy in patients with papain allergy should be investigated in a relatively large cohort.
(Beijing Macro-Union Phamaceutical Co. Ltd., Beijing, China). The patient also exhibited positive skin responses to fresh kiwi fruit (+++) and papain (+++) (0.1 mg/mL). The total IgE level (ImmunoCAP, Phadia, Upsala, Sweden) was 214 kU/L, and specific IgE were positive to kiwi fruit (2.95 kUA/L), papain (>100 kUA/L), and chymopapain (95.0 kUA/L), but negative to latex, common silver birch, mountain juniper, common ragweed, mugwort, and scale len scale. Baseline spirometry results were normal.
Kiwi fruit and papain extracts were analyzed by SDS-PAGE as described by Laemmli. SDS-PAGE analysis of kiwi fruit extract showed multiple protein bands with an apparent molecular mass ranging from 10 to 30 kD, and papain protein showed some smear bands ranging from 10 to 35 kD ( Figure A) . As shown in Figure B , sera from the patient showed IgE binding to 21, 15, and 10 kD proteins in kiwi fruit extracts and papain proteins of 15 KD. We present the 13 published papain allergy cases in Table. In general, most publications were based on isolated case reports and a small series of patients (Table) . A death case due to papain inhalation was reported in 1977. 4 Eighty-five percent (11/13) of the cases were sensitized through respiratory contact, and 40% (4/11) had atopy.
DISCUSSION
Papain-induced occupational asthma is a subtype of work-related asthma (WRA). 11 Its clinical diagnosis was based on typical type I hypersensitivity symptoms on airway exposure to papain, clinical findings, papain positive skin testing, papain-specific IgE, and Western blotting assay.
Similar to previous reported cases, 6, 12 our case showed potential cross-reactivity between papain and kiwi fruit. Although kiwi fruit allergy in our patient was demonstrated by specific IgE levels and Western blotting data, our patient showed different binding patterns to kiwi fruit from published data, which reported actinidin (MW ≈30 kDa) to be the major allergen, 13 differences in the recognition of allergens between populations of kiwi fruit-allergic patients from different countries partly due to genetic, dietary, or other environmental differences, and partly due to variations in kiwi fruit consumed. There are similar bands at 10-15 kDa in blotting with papain and kiwi fruit extracts, which may contribute to cross-reactivity. Further inhibition tests are needed to confirm our results.
There is possible cross-reactivity between papain and fig fruit according to the clinical history of our patient. Similarly, the cross-reactivity between papain and fig fruit has been documented by CAP inhibition, and the association between allergies to fig fruit and papain may be attributed to the presence of cross-reactive allergen structures. 14 Previous studies suggested that papain allergy can occur in both atopic and non-atopic individuals as in our case with an atopic background. Baur et al. 3 reported that although 14 out of the 33 workers had occupational exposure to papain, none of them had pre-existing allergic disease. However, Novey et al. 17 demonstrated that atopic workers develop pulmonary symptoms and anti-papain antibodies significantly earlier after papain exposure than did others and that the concentration of papain, rather than the length of the exposure, is the most important factor for the development of clinical symptoms. Workers who have the greatest amount of dust exposure per workday have significantly more pulmonary symptoms.
Unlike several published studies, 12,16 our patient did not show cross-reactivity between papain and latex due to the absence of Western blotting
latex-specific IgE. Although published data suggested that the presence of cross-reactivity between papain and latex allergens due to IgE binding to some identical regions in papain and latex allergens, the difference may be due to papain IgE in this patient's recognition of other non-identical regions of papain. Due to the high prevalence of sensitization in exposed workers and the potential profile of asthmatic life-threatening attacks, extensive protective measures should be taken to eliminate the risk of sensitization in the professional setting. Sensitized individuals should avoid exposure to both papain and its fruit relatives, e.g. kiwi fruit and fig fruit. Further studies should focus on the determination of cross-reactive allergens. The prevalence of relative fruit allergy in patients with papain allergy should be investigated in a relatively large cohort.
